REX AMERICAN RESOURCES Corp (REX)
Industrial Organic Chemicals · Healthcare · $1.4B
Intrinsic Value (Consensus)
$31.39
Current Price
$43.68
Margin of Safety
-28.1%
28.1% Above Intrinsic Value
Value: $31
Price: $44
Valuation Model Estimates
Current Price: $43.68
DCF (Discounted Cash Flow)
$19.01
Graham Number
$32.29
Earnings Power Value
$24.27
Relative Value (P/E)
$50.00
Dividend Discount Model
Not applicable
—
Consensus Value
$31.39
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
52
Profitability
15/25
Strength
24/25
Valuation
9/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $2.50
- EPS (Forward)
- $2.55
- Book Value
- $18.54
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 10.0%
- Debt/Equity
- 12%
- Revenue Growth
- -14.0%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance